Frontiers | Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis | Cell and Developmental Biology
Clinical trials evaluating the efficacy and safety of antibiotics in... | Download Scientific Diagram
Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years | European Respiratory Society
2019 Idiopathic Pulmonary Fibrosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial - The Lancet Respiratory Medicine
Pirfenidone in idiopathic pulmonary fibrosis: A phase III clinical trial in Japan | Semantic Scholar
The therapy of idiopathic pulmonary fibrosis: what is next? | European Respiratory Society
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development | SpringerLink
Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2022
Clinical Trials | Pulmonary Fibrosis Foundation
The therapy of idiopathic pulmonary fibrosis: what is next? | European Respiratory Society
Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions: Molecular Therapy - Methods & Clinical Development
Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years | European Respiratory Society
Clinical Trials in Idiopathic Pulmonary Fibrosis | IPF Research
Global Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Highlights - 2021
Idiopathic Pulmonary Fibrosis: Clinical Trials
Recent clinical trials on idiopathic pulmonary fibrosis. | Download Table
Selected recent clinical trials in idiopathic pulmonary fibrosis | Download Table
Idiopathic Pulmonary Fibrosis | NEJM
Phase IV IPF Clinical Trials | ILD Collaborative
Ongoing clinical trials in idiopathic pulmonary fibrosis | Download Table
%20Treatment%20for%20Usual%20Interstitial%20Pneumonia.png?md=1 "Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment for Usual Interstitial Pneumonia Clinical Trial | Power")
Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment for Usual Interstitial Pneumonia Clinical Trial | Power
Clinical Trial for Idiopathic Pulmonary Fibrosis - Responsum Health
Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme | Respiratory Research | Full Text
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis - The Lancet Respiratory Medicine
Recent Clinical Trials on Idiopathic Pulmonary Fibrosis | Download Table
Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design | SpringerLink
